• Long-term effectiveness of therapy for common cause of kidney failure

    2 monthes ago - By ScienceDaily

    Among individuals with autosomal dominant polycystic kidney disease, those who were treated with tolvaptan for up to 11 years had a slower rate of kidney function decline compared with historical controls. Annualized kidney function decline rates of tolvaptan-treated patients did not change during follow-up.
    Read more ...

     

  • Brain Iron Levels a New Marker of MS Progression?

    2 monthes ago - By Medscape

    Monitoring levels of iron in specific areas of the brain in patients with multiple sclerosis by using novel MRI may track disease progression and assess treatment efficacy in clinical trials, new research suggests.
    Medscape Medical News
    Read more ...

     

  • Drug in clinical trials for Parkinson's disease offers hope for treating heart failure

    2 monthes ago - By News Medical

    A drug currently in clinical trials for treating symptoms of Parkinson's disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers.
    Read more ...